← FDA Drug Approvals (Drugs@FDA)
LYTENAVA
BLA · Biologics License Application · Sponsor: OUTLOOK THERAPEUTICS, INC. · Approved 2026-07-24
Drug application
- FDA Application #
BLA761320- Application type
- Biologics License Application
- Brand name
- LYTENAVA
- Generic name
- Bevacizumab-Vikg
- Active ingredients
- BEVACIZUMAB-VIKG
- Dosage form
- VIAL
- Route
- SINGLE-DOSE
- Marketing status
- Prescription
- Sponsor
- OUTLOOK THERAPEUTICS, INC.
- First approval
- 2026-07-24
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown